Recent studies indicate that vaccines, including shingles, RSV, Tdap, and flu vaccines, can significantly reduce the risk of dementia and Alzheimer’s disease in older adults. These vaccines prevent infections linked to increased dementia risk, enhancing overall health and quality of… Read More »Four vaccines that reduce your risk of dementia
A new study reveals that the shingles vaccine significantly lowers the risk of cardiovascular events, including heart attacks and strokes. Vaccinated individuals showed a 72.9% reduction in herpes zoster ophthalmicus and an 83.7% decrease in postherpetic neuralgia. The CDC recommends… Read More »Shingles vaccine linked to reduced risk of heart attacks, stroke
A recent study links AS01-adjuvanted RSV and shingles vaccines to a reduced dementia risk in older adults. Findings indicate that the RSV vaccine led to a 29% longer duration without dementia, while the shingles vaccine resulted in 18%. Combined vaccination… Read More »RSV and shingles vaccines linked to a lower risk of dementia
HHS Secretary Robert F. Kennedy Jr. incorrectly claims that Europe does not utilize the chickenpox vaccine, asserting it leads to increased shingles cases. Contrary to his statements, many European countries recommend the vaccine. Additionally, there is no evidence that chickenpox… Read More »RFK Jr says Europe does not use chickenpox vaccine — wrong
A new South Korean study reveals that the shingles vaccine reduces cardiovascular events by 23%, providing additional health benefits beyond preventing shingles. While it does not directly prevent conditions like dementia or heart attacks, it lowers the risk related to… Read More »New study — shingles vaccine reduces cardiovascular events
The herpes zoster (shingles) vaccine significantly lowers the risk of developing dementia, as confirmed by new research. Shingles is a painful condition linked to long-term complications, including cognitive decline. Vaccination is essential for those over 50, offering protection against both… Read More »More evidence herpes zoster (shingles) vaccine delays dementia
Research indicates a potential link between shingles vaccines and reduced dementia risk. A recent study found Zostavax recipients had a 20% lower risk of dementia compared to non-recipients over seven years. This adds to growing evidence that shingles vaccinations, including… Read More »New study shows shingles vaccine tied to reduced dementia risk
GSK is investigating the potential link between its shingles vaccine, Shingrix, and reduced dementia risk among over a million older adults in the UK. The study will analyze health records to provide insights on how the vaccine, which prevents shingles… Read More »GSK is investigating if shingles vaccine reduces risk of dementia
A new study shows that shingles increases the risk of cognitive decline, corroborating earlier findings that the shingles vaccine reduces this risk. The virus can cause serious complications, especially in older individuals. The study highlights the importance of the vaccine,… Read More »New study shows that shingles increases risk of cognitive decline
A new study indicates that the shingles vaccine can reduce the risk of dementia, corroborating earlier findings. Shingles, caused by the Varicella zoster virus, can reemerge later in life, leading to serious health issues. Preventing shingles through vaccination may also… Read More »Dementia risk reduced by shingles vaccine